These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8289862)

  • 1. Thrombolytic therapy for acute myocardial infarction: GUSTO criticized.
    Chelluri L; Sirio CA; Angus DC
    N Engl J Med; 1994 Feb; 330(7):505; author reply 505-6. PubMed ID: 8289862
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolytic therapy for acute myocardial infarction: GUSTO criticized.
    Friedman HS
    N Engl J Med; 1994 Feb; 330(7):504; author reply 505-6. PubMed ID: 8289861
    [No Abstract]   [Full Text] [Related]  

  • 3. Early patency in acute myocardial infarction.
    Belenkie I
    Can J Cardiol; 1993 Mar; 9(2):149-51. PubMed ID: 8490781
    [No Abstract]   [Full Text] [Related]  

  • 4. [Canadian Consensus Conference on Coronary Thrombolysis--current aspects].
    Cairns J; Armstrong P; Belenkie I; Hirsh J; Johnstone D; Knudtson M; Lemieux M; Massel D; Naylor D; Roy L
    Can J Cardiol; 1995; 11(7):581-6. PubMed ID: 7656193
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost effectiveness of tissue plasminogen activator.
    Lee TH
    N Engl J Med; 1995 May; 332(21):1443-4. PubMed ID: 7723804
    [No Abstract]   [Full Text] [Related]  

  • 6. Myocardial infarction, thrombolytic therapy, and economics.
    Shander D
    Clin Cardiol; 1993 Nov; 16(11):845. PubMed ID: 8269667
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.
    Kent DM; Vijan S; Hayward RA; Griffith JL; Beshansky JR; Selker HP
    J Clin Epidemiol; 2004 Aug; 57(8):843-52. PubMed ID: 15485737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombolytic therapy].
    de Gaetano G; Donati MB; Gensini GF; Restagno C
    Recenti Prog Med; 1993 Sep; 84(9):581-5. PubMed ID: 8210621
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the cost-effectiveness of thrombolytic therapy in acute myocardial infarct using tissue plasminogen activator or streptokinase:the Italian perspective].
    Lorenzoni R; Fattore G; Gensini G
    G Ital Cardiol; 1997 Jul; 27(7):721-6. PubMed ID: 9303862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The identification of the best thrombolytic. Reflections on a problem without resolution].
    Betriu A
    Rev Esp Cardiol; 1993 Apr; 46(4):242-5. PubMed ID: 8469809
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thrombolytic therapy of acute myocardial infarction].
    Chen JL
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):69-70. PubMed ID: 15808085
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators.
    Califf RM; Topol EJ
    Clin Cardiol; 1992 Mar; 15(3):143-4. PubMed ID: 1551260
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of acute myocardial infarction in Switzerland: is emergency PTCA more costly than thrombolysis?].
    Hagmann A; Amann W; Urban P; Pfisterer M
    Schweiz Med Wochenschr; 1999 Oct; 129(39):1389-96. PubMed ID: 10542996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic therapy for acute myocardial infarction: GUSTO criticized.
    Ogunyankin K
    N Engl J Med; 1994 Feb; 330(7):505; author reply 506. PubMed ID: 8204156
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials and decisions for thrombolytic therapy in patients with acute myocardial infarction.
    Conti CR
    Clin Cardiol; 1990 May; 13(5):307-8. PubMed ID: 2112073
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fast helicopter ambulance transfer of patients with acute myocardial infarction and thrombolytic therapy (rTPA)].
    De Trana L; Latronico S; Mileti L
    Minerva Anestesiol; 1991 Dec; 57(12):1659-60. PubMed ID: 1795806
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.
    Tsui W; Pierre K; Massel D
    Can J Cardiol; 2005 Apr; 21(5):423-31. PubMed ID: 15861260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombolytic therapy in acute myocardial infarction. Mechanism of action and treatment considerations].
    Roguin A; Manaster J; Roguin N
    Harefuah; 1993 Jun; 124(12):770-5. PubMed ID: 8375772
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocardial infarction, thrombolytic therapy, and economics.
    Conti RC
    Clin Cardiol; 1993 Sep; 16(9):635. PubMed ID: 8242906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.